ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Nephrocare Health Services (NEPHROPLUS.NSE)
Nephrocare Health Services share price today, ATLAS forecast and fair value
Healthcare · Medical Care Facilities · National Stock Exchange of India · India
₹607.40▲ +1.84%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Nephrocare Health Services in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Nephrocare Health Services
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Nephrocare Health Services a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹574.29 and ₹644.00; in 9 out of 10, between ₹518.83 and ₹712.84. Estimated annual volatility is 31%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹61.5B
- Market cap (USD)
- $649M
- P/E ratio
- 71.5
- 52-week high
- ₹781.50
- 52-week low
- ₹446.00
- Revenue (12 months)
- ₹10.5B
- Operating margin
- 14.0%
- Net margin
- 8.1%
What this means
ATLAS does not publish a fair value for NEPHROPLUS.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks NEPHROPLUS.NSE has traded between ₹446.00 and ₹781.50. Today it is 22.3% below that high and 36% above its low.
On the business: net margin is 8.1%; it trades at 71.5 times earnings.
About the company
Nephrocare Health Services Limited is India's largest dialysis-care provider, delivering a full spectrum of renal-care services through an extensive network of clinics across India and select international markets, including the Philippines and Uzbekistan.
Want to see everything about Nephrocare Health Services?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Nephrocare Health Services do?
Nephrocare Health Services Limited is India's largest dialysis-care provider, delivering a full spectrum of renal-care services through an extensive network of clinics across India and select international markets, including the Philippines and Uzbekistan.
What is the chance NEPHROPLUS.NSE goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, NEPHROPLUS.NSE ends the month between ₹574.29 and ₹644.00.
How big is Nephrocare Health Services and what is its P/E ratio?
Nephrocare Health Services's market capitalization is ₹61.5B. Its price-to-earnings (P/E) ratio is 71.5: you pay ₹71.5 for each ₹1.00 of yearly earnings.
How volatile is NEPHROPLUS.NSE?
ATLAS estimates annual volatility at 31%. In a typical month, half of the outcomes end between ₹574.29 and ₹644.00.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer